Pharmaceuticals - Qatar

Qatar

In 2024, it is projected that the revenue of the Pharmaceuticals market in Qatar will reach US$455.00m.
The largest market within this market is Oncology Drugs, with a projected market volume of US$79.89m in the same year.
The revenue is expected to exhibit an annual growth rate of 5.39% (CAGR 2024-2029), resulting in a market volume of US$591.50m by 2029.
When compared globally, United States is anticipated to generate the highest revenue, amounting to US$630.30bn in 2024.
The pharmaceutical market in Qatar is experiencing a surge in demand for innovative and specialized medications.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

Qatar, a small country in the Middle East, is known for its vast oil and gas reserves. However, the country has also been making strides in the healthcare industry, particularly in the Pharmaceuticals market.

Customer preferences: In Qatar, there is a growing demand for pharmaceutical products due to an increase in chronic diseases such as diabetes and hypertension. Additionally, the country has a high per capita income, which allows for a greater affordability of healthcare services and products.

Trends in the market: One trend in the Pharmaceuticals market in Qatar is the increasing focus on research and development. The government has been investing heavily in this area, which has resulted in the country becoming a hub for clinical trials. This has led to the introduction of new and innovative drugs in the market.Another trend is the increasing use of technology in the healthcare industry. Qatar has been investing in digital healthcare solutions, such as telemedicine and electronic health records, which has made healthcare more accessible to the population. This has also led to an increase in online pharmacies, which has made it easier for consumers to purchase pharmaceutical products.

Local special circumstances: Qatar has a relatively small population, which has led to a concentration of healthcare facilities and services in urban areas. This has resulted in a higher demand for pharmaceutical products in these areas. Additionally, the country has a high expatriate population, which has led to a demand for a wider range of pharmaceutical products.

Underlying macroeconomic factors: Qatar's healthcare industry has been driven by the government's efforts to diversify the economy away from oil and gas. The government has been investing heavily in the healthcare industry, which has led to an increase in the number of healthcare facilities and services in the country. Additionally, the country's high per capita income has allowed for greater affordability of healthcare services and products.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.